Admission Date:  [**2195-2-27**]              Discharge Date:   [**2195-3-3**]  Date of Birth:  [**2134-9-9**]             Sex:   F  Service: MEDICINE  Allergies: Dilantin  Attending:[**First Name3 (LF) 2145**] Chief Complaint: Black tarry stools  Major Surgical or Invasive Procedure: EGD s/p epinephrine injection and clipping   History of Present Illness: Ms. [**Known lastname 101213**] is a 60-year-old female with a h/o ESRD on hemodialysis and hypertension presenting with 2 days of melena and coffee-ground emesis.
Two days prior to admission, she reports black stools after hemodialysis (3-4 episodes) as well as three episodes of vomiting with a small amount of dark-red blood.
She had a bedside EGD, was placed on PPI [**Hospital1 **], and had [**Hospital1 **] hct checks.
Prior to arriving to the floor, patient underwent hemodialysis and was tranferred to medicine.
IgA nephropathy in [**2169**] - hemodialysis dependant since [**2193**].
S/p renal transplant in [**2173**], acute on chronic rejection in [**1-25**], now ESRD on hemodialysis.
Has left permacath placed several months ago.
Depression 5. s/p rheumatic fever in childhood 6. h/o seizure in [**5-26**] [**2-21**] HTN per pt, has not been on anti-seizure meds in many months (without further seizures).
ABDOMEN: Normal bowel sounds, slightly hard abdominal muscles, no distension, no tenderness, scar from prior transplant on right.
Brief Hospital Course: 60-year-old female with a h/o ESRD [**2-21**] IgA nephropathy, HD-dependent, anemia, and hypertension presenting from the MICU with upper GI bleed [**2-21**] bleeding duodenal ulcer s/p clipping and cauterization.
Patient received 4units of PRBCs and remained hemodynamically stable.
Per GI recommendations, she was on an IV PPI infusion x72hrs.
H. pylori antibody test returned negative.
# ESRD - Patient has a h/o IgA nephropathy in [**2169**], and a renal transplant in [**2173**].
She suffered transplant rejection in [**2193**] and has since then been receiving hemodialysis TID/[**Year (4 digits) 20515**] in [**Location (un) **].
She reports good adherence to hemodialysis outpatient treatments.
She had hemodialysis x2 while inpatient, and her blood pressure dropped after each treatment to an SBP in the 150s.
While she was inpatient, renal followed her and recommended the addition of Calcium Acetate 667mg TID/with meals given high phosphate levels.
She states that since the beginning of HD in [**2193**], she's noticed worsening mood over recent months.
She was treated with anti-depressants in the past but they caused restless leg syndrome.
Given the concern for suicidal ideation, she was monitored with a sitter while inpatient.
# HTN - At home patient is on labetalol 200mg QID and lisinopril 40mg daily to control her elevated blood pressure.
In the setting of a GI bleed, her hypertensive regimen was held.
However, after her first inpatient hemodialysis and upon transfer to the floor, her blood pressure rose dramatically (SBPs 180-190s) and she was given 10mg IV hydralazine to a minimum effect, she also reported a severe headache and nausea.
Labetalol 200mg QID was re-started with a stable hematocrit at 27.5, and her symptoms resolved and blood pressure dropped to SBPs 140s.
Lisinopril was also restarted and only had a minimum effect on the blood pressure.
Labetalol dosage was increased to 400mg QID.
It is unclear what her baseline blood pressure on medications is at home.
She received IV metoprolol for acute control.
Patient was discharged on an increased regimen of labetalol.
Per renal, a possible future medication that might be beneficial for this patient would be a CCB, such as amlodipine.
She reports that she usually experiences headaches near the end of her dialysis treatment, and both headaches s/p dialysis treatment were similar in character.
She was managed with morphine for pain control.
# Left lower lobe lung collapse: After patient had EGD procedure in the MICU, her oxygen saturation dropped and she began to hyperventilate.
1st CXR revealed LLL collapse, 2nd CXR revealed resolving LLL collapse and LUL non-resolving atelectasis.
Also, she should continue on a PPI indefinitely (see above).
Medications on Admission: 1.  asa 81mg daily 2.  labetalol 400mg tid 3.  lisinopril 40mg qd 4.  sevalamer 1600mg tid   Discharge Medications: 1.
Pantoprazole 40 mg Tablet, Delayed Release (E.C.)
Sevelamer HCl 800 mg Tablet Sig: Two (2) Tablet PO TID W/MEALS (3 TIMES A DAY WITH MEALS).
Lisinopril 20 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).
Labetalol 200 mg Tablet Sig: Two (2) Tablet PO QID (4 times a day).
Calcium Acetate 667 mg Capsule Sig: One (1) Capsule PO TID W/MEALS (3 TIMES A DAY WITH MEALS).
Pantoprazole 40 mg Tablet, Delayed Release (E.C.)
PO once a day: please start Rx after finishing Rx for pantoprazole 40 mg twice a day for 1 month.
)(s)* Refills:*2*   Discharge Disposition: Home  Discharge Diagnosis: Primary Diagnosis: Bleeding duodenal ulcer Non-bleeding gastric ulcer Esophagitis s/p LLL lung collapse  Secondary diagnosis: Hypertension Depression with passive suicidal ideation ESRD on dialysis   Discharge Condition: Good, BPs improved, other VSS, ambulating without difficulty, no further SI.
As a result of the bleeding, you had several units of blood transfused.
You were also continued on dialysis and your blood pressure medication was increased for better control of your blood pressure.
The following changes have been made to your medications: 1) You are being started on a proton pump inhibitor called pantoprazole.
2) Your blood pressure medication labetalol was increased to 400 mg four times a day.
3) You were started on calcium acetate which will need to be taken 3 times a day with meals.
